158 related articles for article (PubMed ID: 36736774)
1. N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations.
Moser J; Ashworth IW; Harris L; Hillier MC; Nanda KK; Scrivens G
J Pharm Sci; 2023 May; 112(5):1255-1267. PubMed ID: 36736774
[TBL] [Abstract][Full Text] [Related]
2. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
[TBL] [Abstract][Full Text] [Related]
3. Trace Aldehydes in Solid Oral Dosage Forms as Catalysts for Nitrosating Secondary Amines.
Harmon P
J Pharm Sci; 2023 May; 112(5):1216-1219. PubMed ID: 36336102
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM
J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183
[TBL] [Abstract][Full Text] [Related]
5. Influence of amine structural characteristics on N-nitrosamine formation potential relevant to postcombustion CO2 capture systems.
Dai N; Mitch WA
Environ Sci Technol; 2013 Nov; 47(22):13175-83. PubMed ID: 24138561
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Formaldehyde-Catalyzed NNitrosation of Dialkyl Amines: An Automated Experimental and Kinetic Modelling Study Using Dibutylamine.
Diab S; Ferrini P; Dominey AP; Whiting MP; Wickens JR; Ashworth IW; Rainey TJ
J Pharm Sci; 2024 Jun; 113(6):1624-1635. PubMed ID: 38307493
[TBL] [Abstract][Full Text] [Related]
7. Solid State Kinetics of Nitrosation Using Native Sources of Nitrite.
Carloni LE; Lochner S; Sterckx H; Van Daele T
J Pharm Sci; 2023 May; 112(5):1324-1332. PubMed ID: 36828125
[TBL] [Abstract][Full Text] [Related]
8. Measurement of nitrosamine and nitramine formation from NOx reactions with amines during amine-based carbon dioxide capture for postcombustion carbon sequestration.
Dai N; Shah AD; Hu L; Plewa MJ; McKague B; Mitch WA
Environ Sci Technol; 2012 Sep; 46(17):9793-801. PubMed ID: 22831707
[TBL] [Abstract][Full Text] [Related]
9. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches.
Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG
Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910
[TBL] [Abstract][Full Text] [Related]
10. Ester-mediated nitrosamine formation from nitrite and secondary or tertiary amines.
Loeppky RN; Tomasik W; Millard TG
IARC Sci Publ; 1984; (57):353-63. PubMed ID: 6533026
[TBL] [Abstract][Full Text] [Related]
11. Modified NAP test: A simple and Responsive Nitrosating Methodology for Risk Evaluation of NDSRIs.
Sharma N; Patel R; Bothara T; Jain S; Shah RP
J Pharm Sci; 2023 May; 112(5):1333-1340. PubMed ID: 36871894
[TBL] [Abstract][Full Text] [Related]
12. The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals.
Schlingemann J; Burns MJ; Ponting DJ; Martins Avila C; Romero NE; Jaywant MA; Smith GF; Ashworth IW; Simon S; Saal C; Wilk A
J Pharm Sci; 2023 May; 112(5):1287-1304. PubMed ID: 36402198
[TBL] [Abstract][Full Text] [Related]
13. Artifactual degradation of secondary amine-containing drugs during accelerated stability testing when saturated sodium nitrite solutions are used for humidity control.
Sluggett GW; Zelesky T; Hetrick EM; Babayan Y; Baertschi SW
J Pharm Biomed Anal; 2018 Feb; 149():206-213. PubMed ID: 29126082
[TBL] [Abstract][Full Text] [Related]
14. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
[TBL] [Abstract][Full Text] [Related]
15. Role of absorber and desorber units and operational conditions for N-nitrosamine formation during amine-based carbon capture.
Wang Z; Zhang Z; Mitch WA
Water Res; 2020 Mar; 170():115299. PubMed ID: 31760360
[TBL] [Abstract][Full Text] [Related]
16. Nitrosamine formation in amine scrubbing at desorber temperatures.
Fine NA; Goldman MJ; Rochelle GT
Environ Sci Technol; 2014; 48(15):8777-83. PubMed ID: 24956458
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products.
Akkaraju H; Tatia R; Mane SS; Khade AB; Dengale SJ
Regul Toxicol Pharmacol; 2023 Mar; 139():105355. PubMed ID: 36792049
[TBL] [Abstract][Full Text] [Related]
18. Specific and total N-nitrosamines formation potentials of nitrogenous micropollutants during chloramination.
Piazzoli A; Breider F; Aquillon CG; Antonelli M; von Gunten U
Water Res; 2018 May; 135():311-321. PubMed ID: 29524858
[TBL] [Abstract][Full Text] [Related]
19. Influence of Dissolved Metals on N-Nitrosamine Formation under Amine-based CO2 Capture Conditions.
Wang Z; Mitch WA
Environ Sci Technol; 2015 Oct; 49(19):11974-81. PubMed ID: 26335609
[TBL] [Abstract][Full Text] [Related]
20. Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy.
Charoo NA; Dharani S; Khan MA; Rahman Z
AAPS PharmSciTech; 2023 Feb; 24(2):60. PubMed ID: 36759424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
